Adaptive Biotechnologies
The Clinical Affairs Manager is a senior individual contributor responsible for planning, executing, and reporting company-sponsored clinical studies to support IVD product submissions and post-market obligations. This role involves building and operationalizing the company’s Clinical Affairs infrastructure, including SOPs and vendor oversight practices, while serving as a key liaison between Regulatory Affairs, Medical Affairs, and other internal stakeholders. The position requires direct hands-on experience running sponsor-side clinical studies under applicable frameworks and authoring clinical sections of regulatory submissions.
Headquarters
Seattle, Washington, United States
Company Size
501-1000 employees
Founded
2009
Adaptive Biotechnologies is a biotechnology company that uses immune system sequencing and machine learning to profile T-cell and B-cell receptors. It develops diagnostics and research tools for detecting disease, monitoring immune responses, and supporting drug discovery.
Adaptive Biotechnologies (NASDAQ:ADPT) Shares Gap Up - What's Next?
2 hours ago
Pier Capital LLC Sells 381,803 Shares of Adaptive Biotechnologies Corporation $ADPT
6 hours ago
Do Insider Sales Align With Adaptive Biotechnologies' (ADPT) MRD-Driven Momentum and Long-Term Strategy?
5 days ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Adaptive Biotechnologies.
5% above the average for this role
TD Cowen is Bullish on Adaptive Biotechnologies Corporation (ADPT)
3 weeks ago
Adaptive Biotechnologies spinout raising $15M to develop clinical sequencing tech
Jan 6, 2026
Regulatory Affairs Consultant – Contract / Ad Hoc Support
MDC Associates
Global Study Lead (Molecular Lab)
Roche
Director, Clinical Affairs
Spryte Medical
Principal Clinical Scientist
CSL Behring Australia
Clinical Research Associate II
Precision Medicine Group
Director, Regulatory Affairs Strategy - Oncology
Regeneron Pharmaceuticals